Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By Freedom Bunker
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

Novo Roundtrips GLP-1 Craze Ahead Of Earnings As Goldman Maps Out Next Wave Of Obesity-Drug Catalysts

% of readers think this story is Fact. Add your two cents.


Novo Roundtrips GLP-1 Craze Ahead Of Earnings As Goldman Maps Out Next Wave Of Obesity-Drug Catalysts

The rollercoaster ride of the GLP-1 craze and bust cycle for Novo Nordisk A/S shares has been wild to observe over the last several years. The stock has since returned to roughly pre-GLP-1-boom levels, down 50% year-to-date amid intensifying obesity-drug competition and a series of profit downgrades.

New Novo CEO Maziar Mike Doustdar will deliver his first set of results as the new head of the Danish pharma company on Wednesday with the reporting of third-quarter earnings. 

Already, Novo has slashed 9,000 jobs globally and cut its profit forecast for the third time this year. 

“Since the new CEO took the helm, early signs indicate a more aggressive approach,” Berenberg analyst Kerry Holford recently told clients, adding that the board reshuffle creates more unexpected disruption, “change at Novo is necessary and may ultimately be a net positive.”

Paul Major, a portfolio manager at Bellevue Asset Management, told Bloomberg, ”The shares have been under pressure all year. It will be interesting to hear what he’s got to say, what he thinks the priorities are, because that’s going to tell us why the board thought he was the right person for the job.”

All Doustdar needs now is to present a solid turnaround plan to convince investors that he’s plugged the holes and stopped the ship from sinking any further.

Despite the steep selloff, Wall Street remains broadly optimistic, with about 56% of analysts rating the stock a “Buy,” 12% “Neutral,” and just 6% “Sell.” The average 12-month price target implies 37% upside from current levels.

Besides Novo, there’s a lot more happening in the obesity space. Goldman Sachs analysts, led by Corinne Johnson, provided clients with a comprehensive breakdown of the upcoming stock-moving developments across Eli Lilly, Novo Nordisk, and other players in the sector.

Professional subscribers can find the full note at our new Marketdesk.ai portal.

Tyler Durden Tue, 11/04/2025 – 08:25


Source: https://freedombunker.com/2025/11/04/novo-roundtrips-glp-1-craze-ahead-of-earnings-as-goldman-maps-out-next-wave-of-obesity-drug-catalysts/


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


LION'S MANE PRODUCT


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

MOST RECENT
Load more ...

SignUp

Login